RCAMU
AVNS

Rothschild & Co Asset Management US’s Avanos Medical AVNS Stock Holding History

Rothschild & Co Asset Management US’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,448
Closed -$616K – 353
2019
Q3 		$616K Sell
16,448
-187
-1% -$7.13K 0.01% 330
2019
Q2 		$725K Sell
16,635
-220
-1% -$9.41K 0.01% 328
2019
Q1 		$719K Buy
+16,855
New +$755K 0.01% 339

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Rothschild & Co Asset Management US's AVNS Position: Q4 2019 in Review

Rothschild & Co Asset Management US sold out of Avanos Medical (AVNS) in Q4 2019, closing a stake of 16,448 shares — an estimated $616K sold.

Rothschild & Co Asset Management US first reported a position in AVNS in Q1 2019 and held it in 3 quarters. The position peaked at $725K in Q2 2019. 293 funds tracked by Wall St. Rank hold AVNS as of Q4 2019.

  • Rothschild & Co Asset Management US reported no remaining Avanos Medical position as of Q4 2019 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 16,448 Avanos Medical shares in Q4 2019, an estimated $616K.
  • Rothschild & Co Asset Management US first reported a position in Avanos Medical in Q1 2019 and held it in 3 quarters.
  • Rothschild & Co Asset Management US's Avanos Medical position peaked at $725K in Q2 2019.
  • 293 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2019.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2019, filed 12 Feb 2020.